Literature DB >> 33712073

If I told you that there is no need for yellow fever vaccine booster would you still come to the travel clinic?: a cross-sectional study.

Iolanda Alves1, Rosa Teodósio2, Filomena Pereira2.   

Abstract

BACKGROUND: Yellow Fever (YF) immunization required a single dose vaccine with boosters every 10 years. After International Health Regulation (IHR) amendment annex 7 (July 2016), it was accepted that a single dose confers lifelong immunity. Since pre-travel advice is as important as vaccination when traveling, it is essential to clarify why travelers come to a travel health consultation, with the possibility of IHR amendment having a negative impact on travelers' health. This study aims to describe travelers' reasons to come to a pre-travel consultation in Lisbon and if they would return if they wouldn't need the YF vaccine booster.
METHODS: An observational cross-sectional study was conducted during 5 months in the waiting room of Instituto de Higiene e Medicina Tropical travel clinic in Lisbon, Portugal. Travelers were asked about sociodemographic characteristics, destination country, travel duration and reasons to travel in an anonymous self-administered questionnaire.
RESULTS: A total of 1043 travelers agreed to participate in the study. Although 61.0% (627/1028) did not come to the clinic to get the YF vaccine, from those who did, 36.7% (133/362) would not come and 12.9% (47/362) didn't knew if they would come if the vaccine would not be necessary.
CONCLUSION: The IHR amendment may have a negative impact on travel clinic attendance and on travelers´ health.

Entities:  

Keywords:  International health regulation amendment; Prevention; Travel health consultation; Travelers; Yellow fever vaccine

Year:  2021        PMID: 33712073      PMCID: PMC7955641          DOI: 10.1186/s40794-021-00132-8

Source DB:  PubMed          Journal:  Trop Dis Travel Med Vaccines        ISSN: 2055-0936


  13 in total

1.  Travellers' profile, travel patterns and vaccine practices--a 10-year prospective study in a Swiss Travel Clinic.

Authors:  Rim Boubaker; Pierrette Meige; Catherine Mialet; Chantal Ngarambe Buffat; Mediatrice Uwanyiligira; Francine Widmer; Jacynthe Rochat; Annie Hérard Fossati; Manisinh Souvannaraj-Blanchant; Sylvie Payot; Laurence Rochat; Serge de Vallière; Blaise Genton; Valérie D'Acremont
Journal:  J Travel Med       Date:  2016-01-20       Impact factor: 8.490

2.  Assessing risk and improving travel vaccine programs for business travelers.

Authors:  William B Bunn
Journal:  J Occup Environ Med       Date:  2014-11       Impact factor: 2.162

3.  No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?

Authors:  Benjamin Wyplosz; Jean-Philippe Leroy; Ouda Derradji; Paul-Henri Consigny
Journal:  J Travel Med       Date:  2014-11-11       Impact factor: 8.490

4.  Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.

Authors:  Rogelio Lopez-Velez; Jose-Maria Bayas
Journal:  J Travel Med       Date:  2007 Sep-Oct       Impact factor: 8.490

5.  Self-reported illness among Boston-area international travelers: A prospective study.

Authors:  Lin H Chen; Pauline V Han; Mary E Wilson; Rhett J Stoney; Emily S Jentes; Christine Benoit; Winnie W Ooi; Elizabeth D Barnett; Davidson H Hamer
Journal:  Travel Med Infect Dis       Date:  2016-10-02       Impact factor: 6.211

6.  Business travel-associated illness: a GeoSentinel analysis.

Authors:  Lin H Chen; Karin Leder; Kira A Barbre; Patricia Schlagenhauf; Michael Libman; Jay Keystone; Marc Mendelson; Philippe Gautret; Eli Schwartz; Marc Shaw; Sue MacDonald; Anne McCarthy; Bradley A Connor; Douglas H Esposito; Davidson Hamer; Mary E Wilson
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

7.  Travelers' health problems and behavior: prospective study with post-travel follow-up.

Authors:  Katri Vilkman; Sari H Pakkanen; Tinja Lääveri; Heli Siikamäki; Anu Kantele
Journal:  BMC Infect Dis       Date:  2016-07-13       Impact factor: 3.090

8.  A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.

Authors:  Rosanne W Wieten; Emile F F Jonker; Ester M M van Leeuwen; Ester B M Remmerswaal; Ineke J M Ten Berge; Adriëtte W de Visser; Perry J J van Genderen; Abraham Goorhuis; Leo G Visser; Martin P Grobusch; Godelieve J de Bree
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

9.  Travel risk behaviors as a determinants of receiving pre-travel health consultation and prevention.

Authors:  Ibrahim Shady; Mohammed Gaafer; Lamiaa Bassiony
Journal:  Trop Dis Travel Med Vaccines       Date:  2015-07-29

10.  Knowledge, attitudes, and practices regarding travel health among Muscat International Airport travelers in Oman: Identifying the gaps and addressing the challenges.

Authors:  Seif S Al-Abri; Doaa M Abdel-Hady; Idris S Al-Abaidani
Journal:  J Epidemiol Glob Health       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.